Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Richard Butler
On June 27, 2025, the president of ALT5 Sigma Corporation was informed of the passing of our longtime director and friend, Richard Butler. He faithfully served as one of our directors since his election to our Board in May 2015 and more recently has been the chair of our Audit Committee and a member of our Compensation Committee and our Nominating and Corporate Governance Committee.
David Danziger
On July 2, 2025, Mr. Danziger, 68, accepted our invitation to become a member of our Board of Directors. For the past 10 years, until his retirement on May 31 2025, David served as Senior Vice President, Assurance and National Leader of Public Companies at MNP LLP, Canada’s 5th largest accounting firm, where he led audit teams across North America and advised companies navigating public market transactions. Since then, he has been Senior Adviser to the firm. David is a seasoned financial executive and public markets advisor with over four decades of experience in audit, compliance, and corporate governance. A Chartered Professional Accountant, Mr. Danziger has served on numerous corporate boards, including TSX-, Nasdaq-, and LSE-listed firms, and has deep expertise in complex financial reporting, governance, and turnaround strategies. He currently sits on several advisory committees, including the TSXV Advisory Committee. Since December 2022, Mr. Danziger has served as a director of Osisko Development Corp., a TSXV- and Nasdaq-listed company. He previously served as a director of Sphere 3D Corp., a Nasdaq-listed company, from December 2022 to May 2024; Euro Sun Mining Inc., a TSX-listed company from September 2010 to January 2023; Pluribus Technologies Corp., a TSXV-listed company, from May 2021 to January 2022; Universal Ibogaine Inc., a TSXV-listed company from October 2021 to June 2022; Eddy Smart Home Solutions Ltd., a TSXV-listed company from February 2021 to January 2022; and Li-Metal Corp., a TSXV-listed company from March 2009 to October 2021. Mr. Danziger will serve as the chair of our Audit Committee and as a member of our Compensation Committee and our Nominating and Corporate Governance Committee. He also is a member of the Advisory Committee to Alyea Therapeutics Corporation and one of its prospective Directors. There was no arrangement or understanding between Mr. Danziger and any other persons, pursuant to which he was selected as a director and there is no family relationship between him and any of our other directors or executive officers. Upon his appointment, we issued to David 10,000 shares of our common stock at a per-share of $7.88, our Historical NOCP as of July 2, 2025 and board fees at the rate of US$1,200 per month. We believe that Mr. Danziger’s four decades of experience in audit, compliance, and corporate governance will bring to our Board further depth in financial, operating, and strategic matters that impact our company.